Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Argus Health
Chinese Patent Office
UBS
Chubb
Deloitte
Teva
Express Scripts
Johnson and Johnson
Daiichi Sankyo

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022041

« Back to Dashboard

NDA 022041 describes CYANOKIT, which is a drug marketed by Serb Sa and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the CYANOKIT profile page.

The generic ingredient in CYANOKIT is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
Summary for 022041
Tradename:CYANOKIT
Applicant:Serb Sa
Ingredient:hydroxocobalamin
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 022041
Medical Subject Heading (MeSH) Categories for 022041
Suppliers and Packaging for NDA: 022041
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041 NDA Meridian Medical Technologies, Inc. 11704-370 11704-370-01 1 VIAL, GLASS in 1 CARTON (11704-370-01) > 250 mL in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength5GM/VIAL (5GM/KIT)
Approval Date:Apr 8, 2011TE:RLD:Yes
Patent:➤ SubscribePatent Expiration:Nov 14, 2016Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2.5GM/VIAL (5GM/KIT)
Approval Date:Dec 15, 2006TE:RLD:No
Patent:➤ SubscribePatent Expiration:Nov 14, 2016Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF KNOWN OR SUSPECTED CYANIDE POISONING

Expired US Patents for NDA 022041

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-002 Dec 15, 2006 ➤ Subscribe ➤ Subscribe
Serb Sa CYANOKIT hydroxocobalamin INJECTABLE;INJECTION 022041-001 Apr 8, 2011 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Cantor Fitzgerald
Teva
Merck
Baxter
US Department of Justice
McKesson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot